Best LL-37 Telehealth Providers for Healing and tissue regeneration
The only known human cathelicidin antimicrobial peptide, naturally produced by immune cells and epithelial tissues. LL-37 has broad-spectrum antimicrobial activity alongside potent immunomodulatory and wound-healing properties.
Reviewed by Dr. James Okafor, PharmDPharmDWhat is LL-37 Used For?
- ✓Antimicrobial defense
- ✓Chronic wound healing
- ✓Immune modulation
- ✓Skin repair
How LL-37 Works
LL-37 is the only known member of the cathelicidin family of antimicrobial peptides in humans. It is produced by neutrophils, macrophages, and epithelial cells as a broad-spectrum antimicrobial defense — disrupting bacterial cell membranes through electrostatic interaction and pore formation. Beyond its antimicrobial function, LL-37 is a potent immunomodulator: it activates innate immune receptors (TLR4, FPRL1), promotes wound healing through growth factor-like signaling, and exhibits anti-biofilm activity against resistant organisms.
What to Expect
For chronic wound healing, improvements in wound tissue granulation and epithelialization are typically reported within 2–4 weeks of topical or local injection. Systemic immune effects from subcutaneous injection vary by indication — chronic infection management protocols typically run 4–12 weeks. The antimicrobial effects are most pronounced in local tissue application.
Common Side Effects
- ⚠Topical: mild burning or stinging at application site
- ⚠Systemic: mild injection site reactions
- ⚠Temporary inflammatory response at high local concentrations
- ⚠Generally well-tolerated in clinical studies
This is not a complete list of side effects. Always consult your prescribing physician before starting LL-37.
Frequently Asked Questions About LL-37
Can LL-37 treat antibiotic-resistant infections?▾
LL-37's mechanism of action (membrane disruption) is fundamentally different from conventional antibiotics, meaning bacterial resistance mechanisms (enzyme degradation, efflux pumps) do not apply in the same way. Research shows activity against MRSA, VRE, and drug-resistant gram-negative organisms. Clinical evidence is still building, but LL-37 is promising for antibiotic-resistant biofilm infections.
Is LL-37 used for skin conditions?▾
Yes — LL-37 is naturally elevated in psoriatic skin and plays a role in the skin's innate immune response. Topical LL-37 is studied for wound healing, eczema, rosacea, and acne. Paradoxically, elevated LL-37 in psoriasis can trigger autoimmune DNA sensing — topical therapeutic use focuses on wound healing rather than psoriasis.
Does LL-37 have anti-cancer properties?▾
Research is mixed. LL-37 shows anti-cancer activity in some cancer models (ovarian, lung, gastric) but pro-cancer activity in others (breast cancer cells). This context-dependence means LL-37 should not be used as a cancer treatment and should be avoided in patients with active malignancy until its role in specific cancer types is better characterized.
How does LL-37 compare to silver or hypochlorous acid for wound care?▾
Silver and hypochlorous acid are broad-spectrum antimicrobial wound care agents that work through oxidative mechanisms. LL-37 adds immunomodulatory, wound-healing-promoting, and anti-biofilm properties beyond simple antimicrobial action. It is most valuable in wounds complicated by infection, poor healing response, or biofilm formation where standard antimicrobials are insufficient.
3 Providers Offering LL-37
Sorted by lowest price first.
| Provider | Price | Dose | Rating | Consultation | Lab Testing |
|---|---|---|---|---|---|
| Amino Asylum United States | $50/one-time | 5mg vial | 3.8/5 | Async Telehealth | Not included |
| Defy Medical Tampa, FL | $180/monthly | Standard protocol | 4.1/5 | Video Telehealth | Included |
| TruLife Health Scottsdale, AZ | $240/monthly | Standard protocol | 4.1/5 | Video Telehealth | Included |